Halia Therapeutics Named as 2025 Top 10 Longevity Breakthrough Award Winner
October 9, 2025
Halia Therapeutics has been named one of the Top 10 Longevity Breakthrough Award Winners for 2025. This recognition reflects Halia’s mission to redefine human potential by addressing the root cause of chronic diseases: inflammation. Congratulations Halia!
Recent News
- Nucleus Institute Convergence Point Groundbreaking
- EDWARDS LIFESCIENCES RECEIVES FDA APPROVAL FOR AUTUS VALVE
- Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4
- Owlet Announces Creation of Baby Safety Task Force to Educate, Innovate, and Advocate for Better Baby Safety Standards
- BD Celebrates 70 Years of Manufacturing, Innovation and Community Partnership in Sandy
- Freyya Closes Oversubscribed Pre-Seed Financing to Advance FDA Regulatory Milestones, Commercialization
